Cure MSA

Country specific patient information

Altangerel K, Sivakumar T, Battsetseg B, Battur B, Ueno A, Igarashi I, Yokoyama N. Phylogenetic relationships of Mongolian Babesia bovis isolates based on the merozoite surface antigen (MSA)-1, MSA-2b, and MSA-2c genes. Veterinary parasitology 2012;184:309-316. https://doi.org/10.1016/j.vetpar.2011.09.021.

 

Baronica KB, Ivkic G, Ozretic D, Milicevic G. Differential diagnostic relevance of high resolution magnetic resonance in patients with possible multiple system atrophy (MSA) - A case report. Collegium antropologicum 2011;35 Suppl 1:287-292.

Barsottini OG, Felicio AC, de Carvalho Aguiar P, Godeiro-Junior C, Pedroso JL, de Aquino CC, Bor-Seng-Shu E, de Andrade LA. Heterozygous exon 3 deletion in the Parkin gene in a patient with clinical and radiological MSA-C phenotype. Clinical neurology and neurosurgery 2011;113:404-406. https://doi.org/10.1016/j.clineuro.2010.11.015.

 

Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW. Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiology of aging 2011;32:548.e545-547. https://doi.org/10.1016/j.neurobiolaging.2009.11.020.

 

Choi JY, Jeong JM, Yoo BC, Kim K, Kim Y, Yang BY, Lee YS, Lee DS, Chung JK, Lee MC. Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography. Nuclear medicine and biology 2011;38:371-379. https://doi.org/10.1016/j.nucmedbio.2010.09.010.

 

Colosimo C. Nonmotor presentations of multiple system atrophy. Nature reviews Neurology 2011;7:295-298. https://doi.org/10.1038/nrneurol.2011.5.

 

De Cock VC, Debs R, Oudiette D, Leu S, Radji F, Tiberge M, Yu H, Bayard S, Roze E, Vidailhet M, Dauvilliers Y, Rascol O, Arnulf I. The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain : a journal of neurology 2011;134:856-862. https://doi.org/10.1093/brain/awq379.

 

Dongmei H, Jing L, Mei X, Ling Z, Hongmin Y, Zhidong W, Li D, Zikuan G, Hengxiang W. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy 2011;13:913-917. https://doi.org/10.3109/14653249.2011.579958.

 

d'Ouince VM, Bories-Desjardins F, Souchon S, Miric D, Hallet-Lezy AM. A report of atypical autopsy-confirmed multiple-system atrophy. Journal of the American Geriatrics Society 2011;59:1354-1355. https://doi.org/10.1111/j.1532-5415.2011.03461.x.

 

Errazquin FP, Heredia MJ, Natera PM. Sign of the cross and MSA-C. Neurologia (Barcelona, Spain) 2011;26:e1-2. https://doi.org/10.1016/j.nrl.2011.01.003.

 

Fernagut PO, Tison F. Animal models of multiple system atrophy. Neuroscience 2012;211:77-82. https://doi.org/10.1016/j.neuroscience.2011.09.044.

 

Fernagut PO, Vital A, Canron MH, Tison F, Meissner WG. Ambiguous mechanisms of dysphagia in multiple system atrophy. Brain : a journal of neurology 2012;135:e205; author reply e206. https://doi.org/10.1093/brain/awr185.

 

Fischer MD, Synofzik M, Heidlauf R, Schicks J, Srulijes K, Kernstock C, Berg D, Schols L, Schiefer U. Retinal nerve fiber layer loss in multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2011;26:914-916. https://doi.org/10.1002/mds.23523.

 

Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM. Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiology of disease 2012;45:188-195. https://doi.org/10.1016/j.nbd.2011.08.003.

 

Fujimori J, Tatewaki Y, Shimizu H, Kimura I, Hisanaga K. [Degeneration of ponto-cerebellar tract visualized by diffusion tensor imaging in multiple system atrophy]. Rinsho shinkeigaku = Clinical neurology 2011;51:271-274.

Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, Low PA, Lee VM, Trojanowski JQ. TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathology and applied neurobiology 2011;37:358-365. https://doi.org/10.1111/j.1365-2990.2010.01136.x.

 

Gillespie D. Toward making the mean spherical approximation of primitive model electrolytes analytic: an analytic approximation of the MSA screening parameter. The Journal of chemical physics 2011;134:044103. https://doi.org/10.1063/1.3544688.

 

Glass PG, Lees AJ, Mathias C, Mason L, Best C, Williams DR, Katzenschlager R, Silveira-Moriyama L. Olfaction in pathologically proven patients with multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2012;27:327-328. https://doi.org/10.1002/mds.23972.

 

Hirohata M, Ono K, Morinaga A, Ikeda T, Yamada M. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro alpha-synuclein fibril formation. Neuroscience letters 2011;491:48-52. https://doi.org/10.1016/j.neulet.2011.01.005.

 

Hong HJ, Song SK, Lee PH, Sohn YH, Lee JE. Cognitive impairments in multiple system atrophy of the cerebellar type. Journal of movement disorders 2011;4:41-45. https://doi.org/10.14802/jmd.11007.

 

Honjo Y, Ito H, Horibe T, Takahashi R, Kawakami K. Protein disulfide isomerase immunopositive glial cytoplasmic inclusions in patients with multiple system atrophy. The International journal of neuroscience 2011;121:543-550. https://doi.org/10.3109/00207454.2011.585440.

 

Ichikawa Y, Goto J, Nakahara Y, Mitsui J, Tsuji S. [Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy]. Rinsho shinkeigaku = Clinical neurology 2011;51:910-913.

Iodice V, Low DA, Vichayanrat E, Mathias CJ. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences. Journal of the neurological sciences 2011;310:133-138. https://doi.org/10.1016/j.jns.2011.07.014.

 

Jellinger K. Unusual tau in MSA. Neuropathology : official journal of the Japanese Society of Neuropathology 2012;32:110-111. https://doi.org/10.1111/j.1440-1789.2011.01246.x.

 

Kakeda S, Korogi Y, Yoneda T, Nishimura J, Sato T, Hiai Y, Ohnari N, Okada K, Hayashi H, Matsusue E, Uozumi T, Tsuji S. A novel tract imaging technique of the brainstem using phase difference enhanced imaging: normal anatomy and initial experience in multiple system atrophy. European radiology 2011;21:2202-2210. https://doi.org/10.1007/s00330-011-2158-7.

 

Kasahara S, Miki Y, Kanagaki M, Kondo T, Yamamoto A, Morimoto E, Okada T, Ito H, Takahashi R, Togashi K. "Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. European journal of radiology 2012;81:2848-2852. https://doi.org/10.1016/j.ejrad.2011.12.012.

 

Kashihara K, Shinya T, Higaki F. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Internal medicine (Tokyo, Japan) 2011;50:1683-1687.

Kikuchi A, Baba T, Hasegawa T, Sugeno N, Konno M, Takeda A. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism & related disorders 2011;17:698-700. https://doi.org/10.1016/j.parkreldis.2011.07.011.

 

Kim HJ, Jeon BS, Lee JY. Serum urate levels are not associated with survival in multiple system atrophy. Parkinsonism & related disorders 2011;17:400-401. https://doi.org/10.1016/j.parkreldis.2011.02.002.

 

Kim HJ, Jeon BS, Lee JY, Yun JY. Survival of Korean patients with multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2011;26:909-912. https://doi.org/10.1002/mds.23580.

 

Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT. Journal of neuroimaging : official journal of the American Society of Neuroimaging 2011;21:132-137. https://doi.org/10.1111/j.1552-6569.2009.00411.x.

 

Kohli J, Brandt N. Multiple-system atrophy and medications: how to minimize the risk of falling. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2011;26:190-196. https://doi.org/10.4140/TCP.n.2011.190.

 

Kollensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK. Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2011;26:507-515. https://doi.org/10.1002/mds.23474.

 

Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Internal medicine (Tokyo, Japan) 2011;50:2775-2781.

Lee JE, Song SK, Sohn YH, Lee PH. Uric acid as a potential disease modifier in patients with multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2011;26:1533-1536. https://doi.org/10.1002/mds.23556.

 

Lee JH, Baik SK. Putaminal hypointensity in the parkinsonian variant of multiple system atrophy: simple visual assessment using susceptibility-weighted imaging. Journal of movement disorders 2011;4:60-63. https://doi.org/10.14802/jmd.11012.

 

Louter M, Pelleboer RH, van den Broek GB, Post B, Pevernagie DA, Overeem S. [Nocturnal stridor in multiple system atrophy]. Nederlands tijdschrift voor geneeskunde 2011;155:A3621.

Madan A, Schiess MC. Intrathecal baclofen therapy slows progressive disability in multiple system atrophy. Neuromodulation : journal of the International Neuromodulation Society 2011;14:176-177; discussion 178. https://doi.org/10.1111/j.1525-1403.2011.00336.x.

 

Maeda R, Yamashita S, Inomata S, Tanaka M, Mizutani T. [Anesthetic management of a patient with multiple system atrophy undergoing adrenal gland tumor surgery]. Masui The Japanese journal of anesthesiology 2011;60:1173-1175.

Makino T, Ito S, Kuwabara S. Involvement of pontine transverse and longitudinal fibers in multiple system atrophy: a tractography-based study. Journal of the neurological sciences 2011;303:61-66. https://doi.org/10.1016/j.jns.2011.01.014.

 

Martinez del Valle Torres MD, Ramos Moreno E, Amrani Raissouni T, Ortega Lozano SJ, Sanz Viedma S, Jimenez-Hoyuela JM. [Functional assessment of nigro-striatal pathway with FP-CIT in patients with multiple system atrophy subtype C]. Medicina clinica 2011;137:440-443. https://doi.org/10.1016/j.medcli.2010.11.020.

 

Masui K, Nakata Y, Fujii N, Iwaki T. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology : official journal of the Japanese Society of Neuropathology 2012;32:69-76. https://doi.org/10.1111/j.1440-1789.2011.01222.x.

 

McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, Leigh PN, Bensimon G. The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom. PloS one 2011;6:e24369. https://doi.org/10.1371/journal.pone.0024369.

 

Mehta AR, Fox SH, Tarnopolsky M, Yoon G. Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype. Movement disorders : official journal of the Movement Disorder Society 2011;26:753-755. https://doi.org/10.1002/mds.23510.

 

Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism & related disorders 2011;17:172-176. https://doi.org/10.1016/j.parkreldis.2010.12.010.

 

Moreno-Lopez C, Santamaria J, Salamero M, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Overeem S, Bloem B, Aarden W, Canesi M, Antonini A, Duerr S, Wenning GK, Poewe W, Rubino A, Meco G, Schneider SA, Bhatia KP, Djaldetti R, Coelho M, Sampaio C, Cochen V, Hellriegel H, Deuschl G, Colosimo C, Marsili L, Gasser T, Tolosa E. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Archives of neurology 2011;68:223-230. https://doi.org/10.1001/archneurol.2010.359.

 

Munoz E, Iranzo A, Rauek S, Lomena F, Gallego J, Ros D, Santamaria J, Tolosa E. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). Journal of neurology 2011;258:2248-2253. https://doi.org/10.1007/s00415-011-6108-8.

 

Nagaishi M, Yokoo H, Nakazato Y. Tau-positive glial cytoplasmic granules in multiple system atrophy. Neuropathology : official journal of the Japanese Society of Neuropathology 2011;31:299-305. https://doi.org/10.1111/j.1440-1789.2010.01159.x.

 

Nakayama K, Suzuki Y, Yazawa I. Binding of neuronal alpha-synuclein to beta-III tubulin and accumulation in a model of multiple system atrophy. Biochemical and biophysical research communications 2012;417:1170-1175. https://doi.org/10.1016/j.bbrc.2011.12.092.

 

Nomura T, Inoue Y, Hogl B, Uemura Y, Yasui K, Sasai T, Namba K, Nakashima K. Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson's disease and multiple system atrophy. Psychiatry and clinical neurosciences 2011;65:264-271. https://doi.org/10.1111/j.1440-1819.2011.02201.x.

 

Oz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum (London, England) 2011;10:208-217. https://doi.org/10.1007/s12311-010-0213-6.

 

Ozawa T, Saji E, Yajima R, Onodera O, Nishizawa M. Reduced bowel sounds in Parkinson's disease and multiple system atrophy patients. Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2011;21:181-184. https://doi.org/10.1007/s10286-010-0102-6.

 

Park HJ, Bang G, Lee BR, Kim HO, Lee PH. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell transplantation 2011;20:827-835. https://doi.org/10.3727/096368910x540630.

 

Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, Durif F, Lacomblez L, Bloch F, Verny M, Fermanian J, Agid Y, Ludolph AC, Leigh PN, Bensimon G. Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale. PloS one 2011;6:e22293. https://doi.org/10.1371/journal.pone.0022293.

 

Pellecchia MT, Barone P, Vicidomini C, Mollica C, Salvatore E, Ianniciello M, Liuzzi R, Longo K, Picillo M, De Michele G, Filla A, Brunetti A, Salvatore M, Pappata S. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Movement disorders : official journal of the Movement Disorder Society 2011;26:1303-1309. https://doi.org/10.1002/mds.23601.

 

Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2012;27:65-71. https://doi.org/10.1002/mds.24000.

 

Pountney DL, Dickson TC, Power JH, Vickers JC, West AJ, Gai WP. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotoxicity research 2011;19:115-122. https://doi.org/10.1007/s12640-009-9146-6.

 

Ragothaman M, Swaminath PV, Sarangmath N, Koshy S, Adhyam M, Subbakrishna DK, Mathias CJ, Muthane UB. Role of dysautonomic symptoms in distinguishing Parkinson's disease (PD) from multiple system atrophy (MSA-P) within a year of developing motor symptoms. The Journal of the Association of Physicians of India 2011;59:95-98.

Rice CM, McGuone D, Kurian KM, Love S, Renowden SA, Giffin NJ. Autopsy-confirmed, co-existent CADASIL and multiple system atrophy. Parkinsonism & related disorders 2011;17:390-392. https://doi.org/10.1016/j.parkreldis.2011.01.004.

 

Rodriguez-Diehl R, Rey MJ, Gironell A, Martinez-Saez E, Ferrer I, Sanchez-Valle R, Jague J, Nos C, Gelpi E. "Preclinical" MSA in definite Creutzfeldt-Jakob disease. Neuropathology : official journal of the Japanese Society of Neuropathology 2012;32:158-163. https://doi.org/10.1111/j.1440-1789.2011.01232.x.

 

Rolland Y, Verin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. Journal of neurology, neurosurgery, and psychiatry 2011;82:1025-1032. https://doi.org/10.1136/jnnp.2010.214890.

 

Sakurai K, Yamawaki T, Okita K, Kato D, Matsukawa N, Kawaguchi T, Kobayashi S, Nagai K, Muto M, Hosono A, Shibamoto Y. Utility of the fluid-attenuated inversion recovery sequence in detecting a hyperintense putaminal rim in multiple system atrophy-parkinsonism: a preliminary study. European neurology 2011;66:42-46. https://doi.org/10.1159/000328674.

 

Samukawa M, Hirano M, Sakamoto H, Kitada M, Kusunoki S, Nakamura Y. Risks of inappropriate secretion of antidiuretic hormone in multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2011;26:2572-2573. https://doi.org/10.1002/mds.23904.

 

Sasaki H, Emi M, Iijima H, Ito N, Sato H, Yabe I, Kato T, Utsumi J, Matsubara K. Copy number loss of (src homology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Molecular brain 2011;4:24. https://doi.org/10.1186/1756-6606-4-24.

 

Schmidt KI, Spiegel J, Reith W. [Clinical and imaging diagnostics of Parkinson's disease and multiple system atrophy]. Der Radiologe 2011;51:273-277. https://doi.org/10.1007/s00117-010-2095-5.

 

Seok HY, Eun MY, Park KW, Yu SW. FDG-PET and MRI features in multiple system atrophy. Acta neurologica Belgica 2011;111:76-77.

Serrao M, Di Fabio R, Bartolo M, Perrotta A, Tassorelli C, Coppola G, Davassi C, Padua L, Sandrini G, Pierelli F. The contribution of trigemino-cervical reflexes in distinguishing progressive supranuclear palsy from multiple system atrophy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2011;122:1812-1815. https://doi.org/10.1016/j.clinph.2011.02.012.

 

Shimohata T, Tomita M, Nakayama H, Aizawa N, Ozawa T, Nishizawa M. Floppy epiglottis as a contraindication of CPAP in patients with multiple system atrophy. Neurology 2011;76:1841-1842. https://doi.org/10.1212/WNL.0b013e31821ccd07.

 

Song SK, Lee SK, Lee JJ, Lee JE, Choi HS, Sohn YH, Lee PH. Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. Neurobiology of aging 2011;32:2183-2189. https://doi.org/10.1016/j.neurobiolaging.2009.12.017.

 

Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotoxicity research 2012;21:393-404. https://doi.org/10.1007/s12640-011-9294-3.

 

Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PloS one 2011;6:e19808. https://doi.org/10.1371/journal.pone.0019808.

 

Stemberger S, Scholz SW, Singleton AB, Wenning GK. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiology of aging 2011;32:1924.e1925-1914. https://doi.org/10.1016/j.neurobiolaging.2011.04.001.

 

Stemberger S, Wenning GK. Modelling progressive autonomic failure in MSA: where are we now? Journal of neural transmission (Vienna, Austria : 1996) 2011;118:841-847. https://doi.org/10.1007/s00702-010-0576-3.

 

Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. BMC neurology 2011;11:157. https://doi.org/10.1186/1471-2377-11-157.

 

Takado Y, Igarashi H, Terajima K, Shimohata T, Ozawa T, Okamoto K, Nishizawa M, Nakada T. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study. Movement disorders : official journal of the Movement Disorder Society 2011;26:1297-1302. https://doi.org/10.1002/mds.23550.

 

Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clinical neurology and neurosurgery 2011;113:823-829. https://doi.org/10.1016/j.clineuro.2011.09.004.

 

Troshin PV, Procter JB, Barton GJ. Java bioinformatics analysis web services for multiple sequence alignment--JABAWS:MSA. Bioinformatics (Oxford, England) 2011;27:2001-2002. https://doi.org/10.1093/bioinformatics/btr304.

 

Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends in neurosciences 2011;34:581-590. https://doi.org/10.1016/j.tins.2011.08.003.

 

Ullman M, Vedam-Mai V, Resnick AS, Yachnis AT, McFarland NR, Merritt S, Zeilman P, Foote KD, Okun MS. Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy. Parkinsonism & related disorders 2012;18:86-88. https://doi.org/10.1016/j.parkreldis.2011.09.008.

 

Umoto M, Miwa H, Ando R, Kajimoto Y, Kondo T. White matter hyperintensities in patients with multiple system atrophy. Parkinsonism & related disorders 2012;18:17-20. https://doi.org/10.1016/j.parkreldis.2011.08.004.

 

Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, Mash DC, Papapetropoulos S, Pahwa R, Lyons KE, Uitti RJ, Wszolek ZK, Dickson DW, Farrer MJ, Ross OA. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 2011;76:670-672. https://doi.org/10.1212/WNL.0b013e31820c30c1.

 

Wakabayashi K. [Glial cytoplasmic inclusions in multiple system atrophy]. Nihon rinsho Japanese journal of clinical medicine 2011;69 Suppl 8:180-184.

Wang PS, Wu HM, Lin CP, Soong BW. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 2011;53:471-481. https://doi.org/10.1007/s00234-010-0757-7.

 

Wang Y, Butros SR, Shuai X, Dai Y, Chen C, Liu M, Haacke EM, Hu J, Xu H. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR American journal of neuroradiology 2012;33:266-273. https://doi.org/10.3174/ajnr.A2765.

 

Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American journal of pathology 2011;178:1509-1516. https://doi.org/10.1016/j.ajpath.2011.01.006.

 

Wang ZF, Wang Q, Wu WP. A case of multiple system atrophy: onset with the cold hands sign. Chinese medical journal 2011;124:1719.

Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Hoglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy. Neuro-degenerative diseases 2011;8:438-446. https://doi.org/10.1159/000325829.

 

Winter Y, Stamelou M, Cabanel N, Sixel-Doring F, Eggert K, Hoglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. Journal of neurology 2011;258:1827-1834. https://doi.org/10.1007/s00415-011-6028-7.

 

Wismeijer AA. Dimensionality Analysis of the Thought Suppression Inventory: Combining EFA, MSA, and CFA. Journal of psychopathology and behavioral assessment 2012;34:116-125. https://doi.org/10.1007/s10862-011-9246-5.

 

Wujtewicz MA, Chwojnicki K, Owczuk R, Wujtewicz M. Laryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2012;33:681-683. https://doi.org/10.1007/s10072-011-0840-9.

 

Yamada M. [Initial cellular target in multiple system atrophy: glial cell]. Rinsho shinkeigaku = Clinical neurology 2011;51:843.

Yamamoto T, Sakakibara R, Uchiyama T, Yamaguchi C, Nomura F, Ito T, Yanagisawa M, Yano M, Awa Y, Yamanishi T, Hattori T, Kuwabara S. Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson's disease. Neurourology and urodynamics 2011;30:102-107. https://doi.org/10.1002/nau.20948.

 

Yavuz A, Inci A, Duzlu O, Biskin Z, Yildirim A. [Molecular characterization of Babesia bovis msa-2c gene]. Turkiye parazitolojii dergisi 2011;35:140-144. https://doi.org/10.5152/tpd.2011.35.

 

Yoon HH, Lee CS, Hong SH, Min J, Kim YH, Hwang O, Jeon SR. Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta neurochirurgica 2012;154:935-940. https://doi.org/10.1007/s00701-011-1133-z.

 

Yoshida M. [Multiple system atrophy - synuclein and neuronal degeneration]. Rinsho shinkeigaku = Clinical neurology 2011;51:838-842.

You H, Wang J, Wang H, Zang YF, Zheng FL, Meng CL, Feng F. Altered regional homogeneity in motor cortices in patients with multiple system atrophy. Neuroscience letters 2011;502:18-23. https://doi.org/10.1016/j.neulet.2011.07.015.

 

Zhu L, Cairns NJ, Tabbal SD, Racette BA. Pregnancy in multiple system atrophy: a case report. Journal of medical case reports 2011;5:599. https://doi.org/10.1186/1752-1947-5-599.